BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $219,000 | -9.5% | 2,828 | 0.0% | 0.09% | -8.0% |
| Q4 2021 | $242,000 | +6.6% | 2,828 | 0.0% | 0.10% | -2.0% |
| Q3 2021 | $227,000 | 0.0% | 2,828 | 0.0% | 0.10% | +2.0% |
| Q2 2021 | $227,000 | -4.6% | 2,828 | 0.0% | 0.10% | -8.3% |
| Q1 2021 | $238,000 | +5.3% | 2,828 | 0.0% | 0.11% | -4.4% |
| Q4 2020 | $226,000 | -0.4% | 2,828 | 0.0% | 0.11% | -6.6% |
| Q3 2020 | $227,000 | -6.6% | 2,828 | 0.0% | 0.12% | -14.7% |
| Q2 2020 | $243,000 | +6.1% | 2,828 | 0.0% | 0.14% | 0.0% |
| Q1 2020 | $229,000 | -28.4% | 2,828 | -26.1% | 0.14% | -4.7% |
| Q4 2019 | $320,000 | -3.0% | 3,828 | +1.2% | 0.15% | -7.4% |
| Q3 2019 | $330,000 | +6.8% | 3,784 | 0.0% | 0.16% | +1.9% |
| Q2 2019 | $309,000 | +0.7% | 3,784 | 0.0% | 0.16% | -3.0% |
| Q1 2019 | $307,000 | +23.3% | 3,784 | -0.0% | 0.16% | +5.8% |
| Q4 2018 | $249,000 | -14.4% | 3,785 | 0.0% | 0.16% | -4.9% |
| Q3 2018 | $291,000 | +4.3% | 3,785 | 0.0% | 0.16% | -1.8% |
| Q2 2018 | $279,000 | -6.4% | 3,785 | -17.4% | 0.17% | -5.1% |
| Q1 2018 | $298,000 | +0.7% | 4,585 | +0.0% | 0.18% | +5.4% |
| Q4 2017 | $296,000 | +3.1% | 4,584 | +0.1% | 0.17% | -2.9% |
| Q3 2017 | $287,000 | +3.6% | 4,580 | 0.0% | 0.17% | +1.2% |
| Q2 2017 | $277,000 | +16.9% | 4,580 | 0.0% | 0.17% | +15.8% |
| Q1 2017 | $237,000 | +5.3% | 4,580 | -10.0% | 0.15% | +5.8% |
| Q4 2016 | $225,000 | -6.6% | 5,090 | +0.5% | 0.14% | -7.4% |
| Q3 2016 | $241,000 | +5.2% | 5,067 | 0.0% | 0.15% | +4.9% |
| Q2 2016 | $229,000 | +10.1% | 5,067 | 0.0% | 0.14% | +3.6% |
| Q1 2016 | $208,000 | -39.5% | 5,067 | +2.8% | 0.14% | -37.7% |
| Q2 2015 | $344,000 | +2.1% | 4,930 | 0.0% | 0.22% | +5.3% |
| Q1 2015 | $337,000 | -6.6% | 4,930 | 0.0% | 0.21% | -4.1% |
| Q4 2014 | $361,000 | +3.1% | 4,930 | +1.0% | 0.22% | 0.0% |
| Q3 2014 | $350,000 | -0.6% | 4,880 | 0.0% | 0.22% | +0.5% |
| Q2 2014 | $352,000 | -1.9% | 4,880 | 0.0% | 0.22% | -10.7% |
| Q1 2014 | $359,000 | +5.9% | 4,880 | 0.0% | 0.24% | +4.7% |
| Q4 2013 | $339,000 | +5.6% | 4,880 | 0.0% | 0.23% | 0.0% |
| Q3 2013 | $321,000 | -5.0% | 4,880 | 0.0% | 0.23% | -9.0% |
| Q2 2013 | $338,000 | – | 4,880 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |